Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_assertion type Assertion NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_head.
- NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_assertion wasGeneratedBy ECO_0000203 NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_provenance.
- NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_assertion wasDerivedFrom befree-20150227 NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_provenance.
- NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_assertion SIO_000772 24520174 NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_provenance.
- NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_assertion evidence source_evidence_literature NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_provenance.
- NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_assertion description "[Thus, indolent human glioma cells deficient for TF remain viable but permanently dormant at the injection site for nearly a year, whereas the expression of TF leads to a step-wise transition to latent and overt tumor growth phases, a process that is preceded by recruitment of vascular (CD105(+)) and myeloid (CD11b(+) and F4/80(+)) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390758.RA6z-xbzOUYM75S3PSc9b01SGg24OJt21DKjMF2QevoXQ130_provenance.